TLX ▼ -2.0% - Telix Pharmaceuticals Limited $TLX - Telix Appoints David Gill as Chair Telix Pharmaceuticals appointed David Gill as Chair, a leadership transition that may have prompted modest profit-taking or investor recalibration around the announcement. The stock declined 2.0% on the news, suggesting the market is either digesting the executive change or responding to broader sector conditions on the day. 31-AUG-2026 06:21 PM ET